Estiar MA - Search Results

1

Clinical significance of NDRG3 in patients with breast cancer.

Estiar MA, Zare AA, Esmaeili R, Farahmand L, Fazilaty H, Jafari D, Samadi T, Majidzadeh-A K. Estiar MA, et al. Future Oncol. 2017 May;13(11):961-969. doi: 10.2217/fon-2016-0457. Epub 2017 Feb 27. Future Oncol. 2017. PMID: 28326836

2

High expression of CEACAM19, a new member of carcinoembryonic antigen gene family, in patients with breast cancer.

Estiar MA, Esmaeili R, Zare AA, Farahmand L, Fazilaty H, Zekri A, Jafarbeik-Iravani N, Majidzadeh-A K. Estiar MA, et al. Clin Exp Med. 2017 Nov;17(4):547-553. doi: 10.1007/s10238-016-0442-1. Epub 2016 Dec 1. Clin Exp Med. 2017. PMID: 27909883

3

MYCN gene amplification in patients with neuroblastic tumors.

Estiar MA, Fazilaty H, Aslanabadi S, Seifi M, Varghaei P, Rezamand A. Estiar MA, et al. Cell Mol Biol (Noisy-le-grand). 2014 Sep 16;60(3):23-8. Cell Mol Biol (Noisy-le-grand). 2014. PMID: 25231001

4

Variants in GNPTAB, GNPTG and NAGPA genes are associated with stutterers.

Kazemi N, Estiar MA, Fazilaty H, Sakhinia E. Kazemi N, et al. Among authors: estiar ma. Gene. 2018 Mar 20;647:93-100. doi: 10.1016/j.gene.2017.12.054. Epub 2017 Dec 28. Gene. 2018. PMID: 29289611

5

Clinical utility of measuring expression levels of Stanniocalcin 2 in patients with colorectal cancer.

Hashemzadeh S, Arabzadeh AA, Estiar MA, Sakhinia M, Mesbahi N, Emrahi L, Ghojazadeh M, Sakhinia E. Hashemzadeh S, et al. Among authors: estiar ma. Med Oncol. 2014 Oct;31(10):237. doi: 10.1007/s12032-014-0237-8. Epub 2014 Sep 19. Med Oncol. 2014. PMID: 25234931

6

Bcl-2 gene expression in human breast cancers in iran.

Rostamizadeh L, Fakhrjou A, Montazeri V, Estiar MA, Naghavi-Behzad M, Hosseini S, Sakhinia M, Sakhinia E. Rostamizadeh L, et al. Among authors: estiar ma. Asian Pac J Cancer Prev. 2013;14(7):4209-14. doi: 10.7314/apjcp.2013.14.7.4209. Asian Pac J Cancer Prev. 2013. PMID: 23991978 Free article.

7

Deregulated expression of HDAC3 in colorectal cancer and its clinical significance.

Nemati M, Ajami N, Estiar MA, Rezapour S, Gavgani RR, Hashemzadeh S, Kafil HS, Sakhinia E. Nemati M, et al. Among authors: estiar ma. Adv Clin Exp Med. 2018 Mar;27(3):305-311. doi: 10.17219/acem/66207. Adv Clin Exp Med. 2018. PMID: 29558042 Free article.

8

HER2 gene amplification in patients with prostate cancer: Evaluating a CISH-based method.

Sharifi N, Salmaninejad A, Ferdosi S, Bajestani AN, Khaleghiyan M, Estiar MA, Jamali M, Nowroozi MR, Shakoori A. Sharifi N, et al. Among authors: estiar ma. Oncol Lett. 2016 Dec;12(6):4651-4658. doi: 10.3892/ol.2016.5235. Epub 2016 Oct 10. Oncol Lett. 2016. PMID: 28105172 Free PMC article.

9

The molecular signature of breast cancer metastasis to bone.

Bahrami T, Mokmeli S, Hossieni H, Pourpaknia R, Makani Z, Salmaninejad A, Estiar MA, Hossieni A, Farshbaf A. Bahrami T, et al. Among authors: estiar ma. Anticancer Drugs. 2016 Oct;27(9):824-31. doi: 10.1097/CAD.0000000000000401. Anticancer Drugs. 2016. PMID: 27384592

10

Prognostic significance of MYCN gene amplification and protein expression in primary brain tumors: Astrocytoma and meningioma.

Estiar MA, Javan F, Zekri A, Mehrazin M, Mehdipour P. Estiar MA, et al. Cancer Biomark. 2017 Jul 4;19(3):341-351. doi: 10.3233/CBM-160546. Cancer Biomark. 2017. PMID: 28453467

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

59 results

Search Page